Spotters in "National Immunization Schedule (NIS) " for CFM & MPH students
For Infants & Children:
1. Vaccine: BCG
Important points:
- Type: Live bacterial, lyophilized
- Strain: Bovine strain Danish-1331
- When to give: At birth or as soon as possible after birth.
- Maximum age: Till one year of age.
- Dose: 0.05 ml until one month, 0.1 ml beyond the age of one month.
- Diluent: Yes, Sodium chloride (Manufacturer-supplied).
- Route: Intra- dermal (ID).
- Site: Upper Arm - LEFT.
- Booster dose: Not required.
- Contraindications: Symptomatic HIV infection, Pregnancy, Radiation therapy (i.e. total-body radiation).
- Possible minor adverse reaction: Local reaction (pain, swelling, redness).
- Expected Frequency: Common.
- Rare vaccine reactions: Suppurative lymphadenitis (2-6 months), BCG osteitis (1-12 months), Disseminated BCG infection (1-12 months).
- Storage: +2 to +8 degree C; Unused reconstituted vaccine should be discarded after 6 hours or at the end of session whichever is earlier. Protect the vaccine from direct sunlight.
- Note: There is no need to revaccinate the child if a scar is not formed after BCG vaccination.
- Protective value: 15 to 20 years, up to 80%.
2. Vaccine: Hepatitis B
Important points:
- Type: Monovalent antigen, subunit genetically engineered plasma-derived vaccine (PDV).
- Composition: 20 mcg of 22 nm surface antigen particles (HbsAg) per ml.
- When to give: Birth dose- At birth or as early as possible.
- Maximum age: Within 24 hours as it helps to prevent perinatal transmission of Hepatitis B.
- Dose: 0.5 ml
- Diluent: No
- Route: Intramuscular
- Site: Antero-lateral side of mid-thigh-LEFT
- Contraindications: Current serious illness.
- Possible minor adverse reaction: Local reaction (pain, swelling, redness), Fever.
- Expected frequency: Adults up to 30%, Children up to 5%.
- Rare vaccine reactions: Anaphylaxis (0-1 hour).
- Storage: +2 to +8 degree C, Never freeze.
- Protective value: Over 95% for 5 years.
3. Vaccine: OPV
Important points:
Type: Live Bivalent
OPV-0:
- When to give: As early as possible.
- Maximum age: within the first 15 days.
- Dose: 2 drops
- Diluent: No
- Route: Oral
OPV-1, 2 & 3:
- When to give: 6, 10 & 14 weeks.
- Maximum age: Up to 5 years of age.
- Dose: 2 drops
- Diluent: No
- Route: Oral
- When to give: 16-24 months.
- Maximum age: Up to 5 years of age.
- Dose: 2 drops
- Diluent: No
- Route: Oral
Possible minor adverse reaction: None
Rare vaccine reactions: VAPP
Storage: +2 to +8 degree C, may be frozen for a long duration.
Protective value: Lifetime
4. Vaccine: IPV
Important points:
- When to give: At 14 weeks.
- Maximum age: Up to one year of age.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra- muscular
- Site: Antero-lateral side of mid-thigh-RIGHT
- Possible minor adverse reaction: None
5. Vaccine: Rotavirus
Important points:
- When to give: At 6, 10 & 14 weeks.
- Maximum age: Up to one year of age.
- Dose: 5 drops.
- Diluent: No
- Route: Oral
- Storage: +2 to +8 degree C.
- Protective value: 80%
- Rotavirus vaccine is being introduced in phases.
6. Vaccine: Pentavalent
Important points:
- It contains a combination of DPT, Hepatitis B & Hib.
- Pentavalent vaccine is introduced in place of DPT and Hep B 1, 2 & 3 .
- When to give: At 6, 10 & 14 weeks.
- Maximum age: Up to one year of age.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Antero-lateral side of mid-thigh-LEFT
- Storage: +2 to +8 degree C.
- When to give: 16-24 months.
- Maximum age: Up to 7 years of age.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Antero-lateral side of mid-thigh-LEFT
- When to give: 5-6 years.
- Maximum age: Up to 7 years of age.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Upper arm-LEFT
- When to give: 10 years & 16 years.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Upper arm.
- Storage: +2 to +8 degree C, never freeze.
- Note: Td - Tetanus diphtheria to replace TT - to be added in schedule.
7. Vaccine: Measles
Important points:
1st dose:
- When to give: 9-12 completed months.
- Maximum age: Up to 5 years of age.
- Dose: 0.5 ml
- Diluent: Sterile water
- Route: Subcutaneous
- Site: Right upper arm
2nd dose:
- When to give: 16-24 months.
- Maximum age: Up to 5 years of age.
- Dose: 0.5 ml
- Diluent: Sterile water
- Route: Subcutaneous
- Site: Right upper arm
- Storage: +2 to +8 degree C, may be frozen during long storage.
- Protective value: Lifetime.
Contraindications: Pregnancy, Radiation therapy.
Possible minor adverse reaction: Local reactions (pain, swelling, redness); irritability, malaise & non-specific symptoms.
Rare vaccine reactions: Febrile seizures
Note: MR vaccine introduced in phases replacing measles vaccine in the UIP schedule. If first dose delayed beyond 12 months ensure minimum one month gap between 2 MR doses.
8. Vaccine: JE
Important points:
1st dose:
- When to give: 9-12 completed months.
- Maximum age: Up to 15 years of age.
- Dose: 0.5 ml
- Diluent: Phosphate buffer
- Route: Subcutaneous
- Site: Left upper arm
2nd dose:
- When to give: 16-24 months.
- Dose: 0.5 ml
- Diluent: Phosphate buffer
- Route: Subcutaneous
- Site: Left upper arm
- Storage: +2 to +8 degree C.
- Protective value: About 3 years.
Possible minor adverse reaction: Local reactions, Low-grade fever, myalgia, gastrointestinal upset.
Rare vaccine reactions: Neurologic events (encephalitis, encephalopathy, peripheral neuropathy).
Note: JE vaccine has been introduced in select endemic districts. If first dose is delayed beyond 12 months ensure minimum 3 months gap between 2 JE doses.
9. Vaccine: Vitamin A
Important points:
1st dose:
- When to give: At 9 completed months with measles.
- Maximum age: Up to 5 years of age.
- Dose: 1 ml (1 lake IU)
- Diluent: No
- Route: Oral
2nd-9th dose:
- When to give: At 16 months, then one dose every 6 months.
- Maximum age: Up to 5 years of age.
- Dose: 2 ml (2 lake IU)
- Diluent: No
- Route: Oral
- The 2nd to 9th doses of Vitamin A can be administered to children 1-5 years old during biannual rounds, in collaboration with ICDS.
For pregnant women:
10. Vaccine: TT
Important points:
1st dose:
- When to give: Early in pregnancy.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Upper arm
2nd dose:
- When to give: 4 weeks after TT-1.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: Upper arm
- When to give: If received TT doses in pregnancy within the last 3 years.
- Dose: 0.5 ml
- Diluent: No
- Route: Intra-muscular
- Site: upper arm
Possible minor adverse reaction: Local reactions (pain, swelling, redness); malaise & non-specific symptoms.
Rare vaccine reactions: Brachial neuritis, Anaphylaxis.
Note: Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give TT to a woman in labor, if she has not previously received TT.
References:
- Park, K. (2019). Park's textbook of preventive and social medicine. 25th. Jabalpur, India: M/S Banarsidas Bhanot.
- Kadri AM. (2019). IAPSM's Textbook of Community Medicine. 1st. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd.
- https://www.indiamart.com/proddetail/bcg-vaccine-5068383112.html photo credit
- https://www.gponline.com/journals-watch-bcg-vaccine-exercise/article/1104980 photo credit
- https://mvec.mcri.edu.au/references/bcg-vaccine/ photo credit
- https://www.quora.com/Whats-the-full-form-of-BCG photo credit
- https://www.indiamart.com/proddetail/hepatitis-b-vaccine-injection-12423014588.html photo credit
- https://www.indiamart.com/proddetail/hivac-b-hepatitis-b-vaccine-13778965697.html photo credit
- https://www.who.int/immunization_standards/vaccine_quality/vvm_use_availability_7sep10.pdf photo credit
- https://www.indiamart.com/proddetail/oral-polio-vaccine-15626476573.html photo credit
- https://polioeradication.org/polio-today/polio-prevention/the-vaccines/opv/ photo credit
- https://zeenews.india.com/news/health/health-news/inactivated-polio-vaccine-ipv-a-new-tool-in-the-fight-against-polio-watch-to-know-more-about-it_1880645.html photo credit
- http://edithzikpi.blogspot.com/2018/06/inactivated-polio-vaccine-introduced.html?m=1 photo credit
- https://www.who.int/immunization_standards/vaccine_quality/PQ_184_bOPV13_GSK_10_dose/en/ photo credit
- https://health.economictimes.indiatimes.com/news/pharma/sii-invents-the-first-ever-heat-stable-rotavirus-vaccine-in-the-world-rotasiil/70712802 PHOTO CREDIT
- https://www.cdc.gov/vaccines/vpd/rotavirus/index.html PHOTO CREDIT
- https://www.indiamart.com/proddetail/rota-virus-vaccine-10369163588.html photo credit
- https://www.congruentpharmaceutical.com/rotavac-5032209.html photo credit
- https://www.downtoearth.org.in/tag/world-immunisation-week photo credit
- https://en.vietnamplus.vn/pentavalent-vaccine-combe-five-to-be-used-nationwide/143808.vnp photo credit
- http://vbch.dnh.nic.in/pdf/penta.pdf photo credit
- https://abcnews.go.com/Health/number-measles-cases-1000-us-time-eradication/story?id=63606750 photo credit
- https://abcnews.go.com/Health/number-measles-cases-1000-us-time-eradication/story?id=63606750 photo credit
- https://www.who.int/immunization_standards/vaccine_quality/pq266_je_1dose_biologicale/en/ photo credit
- https://www.empr.com/home/news/fda-approves-accelerated-vaccination-schedule-for-ixiaro/ photo credit
- https://www.indiamart.com/proddetail/pharma-jenvac-7555738812.html photo credit
- https://www.path.org/articles/how-once-little-used-vaccine-now-protects-millions-japanese-encephalitis/ photo credit
- https://blogs.unicef.org/evidence-for-action/vitamin-supplements-can-save-childs-life/ photo credit
- https://www.jaypeedigital.com/eReader/chapter/9789351527794/ch3 photo credit
- https://www.indiamart.com/proddetail/tt-vaccine-14701227955.html photo credit
- https://www.historyofvaccines.org/index.php/content/tetanus-toxoid-india photo credit
Comments
Post a Comment